HIGH POINT, N.C.--(BUSINESS WIRE)--Jul. 6, 2016--
vTv Therapeutics Inc. (Nasdaq:VTVT), a clinical-stage biopharmaceutical
company engaged in the discovery and development of new orally
administered treatments for Alzheimer’s disease and diabetes, today
announced that Company management will present a corporate overview at
Cantor Fitzgerald’s 2nd Annual Healthcare Conference on Wednesday, July
13, 2016 at 8:00 a.m. ET in New York City.
A live webcast of the presentation can be accessed on the News
& Events section of the website. The webcast will be
archived for 30 days following the presentation on the company website
at www.vtvtherapeutics.com.
About vTv Therapeutics
vTv Therapeutics Inc. is a clinical-stage biopharmaceutical company
engaged in the discovery and development of orally administered small
molecule drug candidates to fill significant unmet medical needs. vTv
has a pipeline of clinical drug candidates led by programs for the
treatment of Alzheimer’s disease and Type 2 diabetes as well as
treatment of inflammatory disorders and the prevention of muscle
weakness.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160706005257/en/
Source: vTv Therapeutics Inc.
Investors
The Trout Group
Michael Gibralter, 646-378-
2938
mgibralter@troutgroup.com
or
Media
BMC
Communications
Brad Miles, 646-513- 3125
bmiles@bmccommunications.com
